Amarin reported $-13151000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 3179M 2413M
Acceleron Pharma XLRN:US $ -70.46M 6.94M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Aerie Pharmaceuticals AERI:US $ -39.69M 1M
Alnylam Pharmaceuticals ALNY:US $ -204.51M 14.96M
Amarin AMRN:US $ -13.15M 20.96M
Arena Pharmaceuticals ARNA:US $ -196.31M 50.22M
AstraZeneca AZN:LN -1652M 2202M
Biocryst Pharmaceuticals BCRX:US $ -58.8M 15.6M
Epizyme EPZM:US $ -65.83M 1.47M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
GlaxoSmithKline GSK:LN 1168M 227M
Halozyme Therapeutics HALO:US $ 216.59M 125.13M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
JAZZ PHA JAZZ:US $ -52.83M 310.48M
Nektar Therapeutics NKTR:US $ -129.71M 4.19M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Novartis NOVN:VX SF 2758M 138M
Teva Pharmaceutical Industries TEVA:US $ 290M 83M